1-20 of 626
cardiovascular diseases
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inotuzumab Ozogamicin Is an Effective Salvage Therapy in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia with High-Risk Molecular Features, Including TP53 Loss

Xiaochuan Yang, Amber C. King, PharmD, BCOP, Charlene C. Kabel, PharmD, Christopher J. Forlenza, MD, Jae H. Park, MD, Mark B. Geyer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3888.
https://doi.org/10.1182/blood-2019-125165
Published: 2019
Journal Articles

Sequential Combination of Inotuzumab Ozogamicin (InO) with Low-Intensity Chemotherapy (Mini-hyper-CVD) with or without Blinatumomab Is Highly Effective in Patients (pts) with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (ALL) in First Relapse

Koji Sasaki, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Nicholas J. Short, MD, Partow Kebriaei, MD, Xuelin Huang, PhD, Michael E. Rytting, MD, Nitin Jain, MD, Marina Y Konopleva, MD PhD, Guillermo Garcia-Manero, MD, Richard E. Champlin, MD, Tapan M. Kadia, MD, Jorge E. Cortes, MD, Zeev E. Estrov, MD, Koichi Takahashi, MD, Christopher Loiselle, BS, Corabelle Encarnacion, RDC, Meagan Rostykus, RN, Rita Khouri, Patrice Nasnas, MD, Jovitta Jacob, RN, Monica Kwari, BSN, Rebecca Garris, MSc, Elias Jabbour, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3806.
https://doi.org/10.1182/blood-2019-129018
Published: 2019
Journal Articles

Immune Sculpting of Clonal Hematopoiesis in Advanced and Metastatic Solid Tumors

Eti Sinha, Bhavneet Binder, Olivier Elemento, PhD, Duane C. Hassane, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3721.
https://doi.org/10.1182/blood-2019-132222
Published: 2019
Journal Articles

A Phase 1/2 Study of Quizartinib (Q) in Combination with Re-Induction Chemotherapy and As Single-Agent Continuation Therapy in Pediatric and Young Adult Patients with Relapsed/Refractory (R/R) FLT3 -ITD Acute Myeloid Leukemia (AML)

C. Michel Zwaan, MD PhD, Edward Anders Kolb, MD, Derek E. Mires, PharmD, Michele Vigliotti, PharmD, Jingdong Xie, PhD, Pamela Downs, BS, Arthur P DeCillis, MD MS, Cara A Rabik, MD PhD, Todd M Cooper, DO
Journal: Blood
Blood (2019) 134 (Supplement_1): 3937.
https://doi.org/10.1182/blood-2019-121736
Published: 2019
Journal Articles

A Multicenter Phase I Study Combining Venetoclax with Mini-Hyper-CVD in Older Adults with Untreated and Relapsed/Refractory Acute Lymphoblastic Leukemia

Nitin Jain, MD, Kristen E. Stevenson, MS, Eric S. Winer, MD, Jacqueline S Garcia, MD, Richard M. Stone, MD, Elias Jabbour, MD, Farhad Ravandi, MD, Jeremy M. Stewart, BA, Dean R Legg, BA, Hagop M. Kantarjian, MD, Donna S Neuberg, ScD, Anthony G. Letai, MD PhD, Marina Y Konopleva, MD PhD, Daniel J. DeAngelo, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3867.
https://doi.org/10.1182/blood-2019-129988
Published: 2019
Journal Articles

Safety and Toxicity Profile of Pembrolizumab (PEM) in Combination with ICE Chemotherapy Followed By Autologous Stem Cell Transplantation for Relapsed/Refractory Classical Hodgkin Lymphoma: No Impairment in Stem Cell Mobilization or Engraftment

Locke J. Bryan, MD, Scott E. Smith, MD PhD, Pamela Allen, MDMSc, Carla Casulo, Brett Alan Palmer, BS, Reem Karmali, MD, Barbara Pro, MD, Denise M Scholtens, PhD, Hatice Savas, MD, Jayesh Mehta, MD, Leo I. Gordon, MD, Jane N. Winter, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4029.
https://doi.org/10.1182/blood-2019-123879
Published: 2019
Journal Articles

Alpine: Phase 3 Trial of Zanubrutinib (BGB-3111) Vs Ibrutinib in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Peter Hillmen, MD PhD, Jennifer R. Brown, MD PhD, John C. Byrd, MD, Barbara F. Eichhorst, MD, Nicole Lamanna, MD, Susan M. O'Brien, MD, Lugui Qiu, MD PhD, Tommi Salmi, MD, James Hilger, PhD, Jane Huang, MD, Constantine S. Tam, MBBS, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4307.
https://doi.org/10.1182/blood-2019-124213
Published: 2019
Journal Articles

CD39 As a Master Regulator of Pulmonary Thrombosis in Sickle Cell Disease

Tomasz Brzoska, PhD, Egemen Tutuncuoglu, MSc, Stevan P. Tofovic, Edwin K. Jackson, Mark T Gladwin, MD, Prithu Sundd, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2266.
https://doi.org/10.1182/blood-2019-130882
Published: 2019
Journal Articles

Manifestations of Reduced Kidney Function Occur at a Higher Estimated Glomerular Filtration Rate in Sickle Cell Anemia

Santosh L. Saraf, MD, Vimal K. Derebail, MD, Xu Zhang, PhD, Mark T Gladwin, MD, Victor R Gordeuk, MD, Jane A. Little, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2268.
https://doi.org/10.1182/blood-2019-124737
Published: 2019
Journal Articles

Risk Factors for Kidney Disease in Hb SC and Hb Sβ + -Thalassemia Sickle Cell Disease

Mandella Mensah, Binal N. Shah, Xu Zhang, PhD, Jin Han, PharmD, PhD, Michel Gowhari, DO, Robert E. Molokie, MD, Mark T Gladwin, MD, Victor R Gordeuk, MD, Santosh L. Saraf, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2299.
https://doi.org/10.1182/blood-2019-128668
Published: 2019
Journal Articles

Characteristics and Clinical Outcomes of Patients with Acute Lymphoblastic Leukemia with KMT2A ( MLL ) Rearrangement

Guillaume Richard-Carpentier, MD, Hagop M. Kantarjian, MD, Guilin Tang, MD, C. Cameron Yin, MD PhD, Joseph D. Khoury, MD, Ghayas C. Issa, MD, Nitin Jain, MD, Farhad Ravandi, MD, Nicholas J. Short, MD, Courtney D. DiNardo, MDMSc, Koichi Takahashi, MD, Maro Ohanian, DO, Gautam M. Borthakur, MD, Marina Y Konopleva, MD PhD, Naval G. Daver, MD, Zeev E. Estrov, MD, Yesid Alvarado, MD, Alessandra Ferrajoli, MD, Tapan M. Kadia, MD, Guillermo Garcia-Manero, MD, Srdan Verstovsek, MD PhD, Rebecca Garris, MSc, Jorge E. Cortes, MD, Susan O'Brien, MD, Elias Jabbour, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2582.
https://doi.org/10.1182/blood-2019-130864
Published: 2019
Journal Articles

Safety and Efficacy of Mitoxantrone Hydrochloride Liposome in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma and Extranodal NK/T-Cell Lymphoma: A Multicenter, Single-Arm, Open-Label, Phase 2 Clinical Trial

Hui-qiang Huang, Yunhong Huang, MD PhD, Gao Yan, Haiyan Yang, Qingyuan Zhang, Runxiang Yang, Min Zhou, PhD, Yufu Li, Yan Li, Lihong Liu, Hui Zhou, MD PhD, Hongmei Jing, Zhigang Peng, MD, Ding Yu, Rong yan Zhang, Bing Xu, Xiaohong Zhang, Junyuan Qi, Liping MA, MD, Shan Chen, Jianfei Xue
Journal: Blood
Blood (2019) 134 (Supplement_1): 2838.
https://doi.org/10.1182/blood-2019-126481
Published: 2019
Journal Articles

Risk Factors and Trends for Incidence of Acute Coronary Syndrome after Hematopoietic Stem Cell Transplant - a 15-Year Experience with National Inpatient Sample

Jasdeep Singh Sidhu, MBBS, Jeevanjot Kaur Virk, MBBS, Shivani Handa, MBBS, Amrendra Mandal, Sridevi Rajeeve, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4564.
https://doi.org/10.1182/blood-2019-127487
Published: 2019
Journal Articles

To Study the Coagulation Profile Derangements in Metabolic Syndrome

Jitender Khunger, Monica Malhotra, MD, Nitin Kumar, MD, VPS Punia, MD, Mohan Agarwal, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4959.
https://doi.org/10.1182/blood-2019-125048
Published: 2019
Journal Articles

An Evaluation of Major Comorbidities and Treatment Patterns of Newly Diagnosed Acute Myeloid Leukemia Patients: A Retrospective Analysis of Electronic Medical Records from US

Nora Tu, PhD, Zahidul Islam, MPH, Albert E Fliss, PhD, Maribel Salas, MD DSc, MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 5106.
https://doi.org/10.1182/blood-2019-124517
Published: 2019
Journal Articles

A Phase 3 Trial Comparing the Efficacy and Safety of Acalabrutinib in Combination with Venetoclax with or without Obinutuzumab, Compared with Investigator's Choice of Chemoimmunotherapy in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) without Del(17p) or TP53 Mutation

Jennifer R Brown, MD PhD, Barbara F. Eichhorst, MD, Paolo Ghia, MD PhD, Arnon P. Kater, MD PhD, Jianyong Li, MD, Sudha Khurana, Mostafa Elhamy, Min Hui Wang, PhD, John F. Seymour, MBBS, PhD FRACP
Journal: Blood
Blood (2019) 134 (Supplement_1): 4318.
https://doi.org/10.1182/blood-2019-123057
Published: 2019
Journal Articles

Peripheral Blood Cytopenia and Subsequent Risk of Cardiovascular Disease and Mortality

Radhika Gangaraju, MD, Insu Koh, PhD, Marguerite R. Irvin, PhD, Leslie A. Lange, PhD, Damon E. Houghton, MDMS, Diego A Herrera, MD, Monika Safford, MD, Mary Cushman, MD, Smita Bhatia, MDMPH, Neil A. Zakai, MDMSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 5002.
https://doi.org/10.1182/blood-2019-125956
Published: 2019
Journal Articles

Increased Frequency of Thromboses Among Patients with Philadelphia (Ph) Negative Myeloproliferative Neoplasms in New Mexico: The Role of Prothrombotic Risk Factors

Qiuying Selina Liu, MD, Shashank Y. Cingam, MBBS, Khine Z Win, MD, Tawny Boyce, MS, MPH, Cecilia Y. Arana Yi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5379.
https://doi.org/10.1182/blood-2019-132142
Published: 2019
Journal Articles

Updated Results of a Phase II Study of Reduced-Intensity Chemotherapy with Mini-Hyper-CVD in Combination with Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

Nicholas J. Short, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Xuelin Huang, PhD, Nitin Jain, MD, Koji Sasaki, MD, Rita Khouri, Naval G. Daver, MD, Naveen Pemmaraju, MD, Joseph D. Khoury, MD, Jeffrey L. Jorgensen, MD PhD, Yesid Alvarado, MD, Marina Y Konopleva, MD PhD, Guillermo Garcia-Manero, MD, Tapan M. Kadia, MD, Musa E. Yilmaz, MD, Gautam M. Borthakur, MD, Jan A. Burger, MD PhD, Steven M. Kornblau, MD, William G. Wierda, MD PhD, Courtney D. DiNardo, MD MSc, Alessandra Ferrajoli, MD, Jovitta Jacob, RN, Meagan Rostykus, RN, Rebecca Garris, MSc, Marygrace Ward, RDC, Binru Huang, RDC, Corabelle Encarnacion, RDC, Christopher Loiselle, BS, Susan M. O'Brien, MD, Elias Jabbour, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 823.
https://doi.org/10.1182/blood-2019-125136
Published: 2019
Journal Articles

Mechanism of Pulmonary Thrombosis in Hemolytic Disorders

Tomasz Brzoska, PhD, Margaret F. Bennewitz, PhD, Egemen Tutuncuoglu, MSc, Margaret V. Ragni, MD MPH, Matthew D Neal, MD, Mark T Gladwin, MD, Prithu Sundd, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 976.
https://doi.org/10.1182/blood-2019-130592
Published: 2019